
Michael Overman and Myriam Chalabi
Jul 7, 2025, 05:32
Myriam Chalabi: Great Overview by Michael Overman of pMMR CRC
Myriam Chalabi, Medical Oncologist and Cancer Immunotherapy researcher, Gastrointestinal Oncology at Antoni van Leeuwenhoek, shared on X:
“Great overview by Michael Overman of pMMR CRC and efforts to modulate for immunotherapy response. Important to learn from negative studies, but also consider that responses might be different in earlier disease stages.”
More posts featuring ESMOGI25.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 7, 2025, 05:32
Jul 6, 2025, 19:46
Jul 6, 2025, 19:33
Jul 6, 2025, 18:44